CSS
DYN icon

Cubist Systematic Strategies’s Dyne Therapeutics DYN Stock Holding History

Cubist Systematic Strategies’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-278,362
Closed -$2.65M – 3132
2025
Q2 		$2.65M Buy
278,362
+162,828
+141% +$1.79M 0.01% 1409
2025
Q1 		$1.21M Sell
115,534
-3,531
-3% -$50.5K 0.01% 1716
2024
Q4 		$2.81M Buy
+119,065
New +$3.52M 0.02% 1165
2024
Q2 		– Sell
-42,817
Closed -$1.22M – 3241
2024
Q1 		$1.22M Buy
+42,817
New +$968K 0.01% 2013
2023
Q2 		– Sell
-27,240
Closed -$314K – 3693
2023
Q1 		$314K Sell
27,240
-2,152
-7% -$27.9K ﹤0.01% 2966
2022
Q4 		$341K Buy
29,392
+2,362
+9% +$27.3K ﹤0.01% 3276
2022
Q3 		$343K Buy
27,030
+26,874
+17,227% +$308K ﹤0.01% 3443
2022
Q2 		$1K Sell
156
-1,157
-88% -$7.97K ﹤0.01% 4326
2022
Q1 		$13K Sell
1,313
-11,969
-90% -$102K ﹤0.01% 3486
2021
Q4 		$158K Buy
13,282
+4,904
+59% +$68.9K ﹤0.01% 3099
2021
Q3 		$136K Buy
8,378
+7,466
+819% +$132K ﹤0.01% 2680
2021
Q2 		$19K Buy
+912
New +$17.1K ﹤0.01% 2850
2021
Q1 		– Sell
-10,031
Closed -$211K – 2860
2020
Q4 		$211K Buy
+10,031
New +$198K ﹤0.01% 2214

Other funds holding DYN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cubist Systematic Strategies's DYN Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Dyne Therapeutics (DYN) in Q3 2025, closing a stake of 278,362 shares — an estimated $2.65M sold.

Cubist Systematic Strategies first reported a position in DYN in Q4 2020 and held it in 13 quarters. The position peaked at $2.81M in Q4 2024. 207 funds tracked by Wall St. Rank hold DYN as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Dyne Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 278,362 Dyne Therapeutics shares in Q3 2025, an estimated $2.65M.
  • Cubist Systematic Strategies first reported a position in Dyne Therapeutics in Q4 2020 and held it in 13 quarters.
  • Cubist Systematic Strategies's Dyne Therapeutics position peaked at $2.81M in Q4 2024.
  • 207 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.